FREE TOOL · LIVE DATA
BCRX DCF Calculator
Run your own discounted cash flow valuation for BioCryst Pharmaceuticals, Inc.. The calculator is pre-filled with real data — $0.3B free cash flow (FY2025) and the live share price — so you only adjust the assumptions.
SEARCH STOCK
Search to auto-fill real company data
COMPANY DATA
YOUR ASSUMPTIONS
YOUR DCF RESULT
CALCULATED FAIR VALUE
$37.19
MARKET
$10.99
YOUR DCF
$37.19
MARGIN
$26.20
VALUE BREAKDOWN
SENSITIVITY CHECK
Try adjusting growth rate by ±2% and discount rate by ±1% to see how sensitive your fair value is to assumptions.
COMPARE WITH FPI FAIR VALUE
Your DCF reflects your assumptions. As an independent reference, here is Fair Price Index's daily blended fair value for BioCryst Pharmaceuticals, Inc. — DCF (50%), relative valuation (30%), and analyst consensus (20%):
Frequently Asked Questions
What is BCRX's free cash flow?
BioCryst Pharmaceuticals, Inc. generated $0.3 billion of free cash flow in fiscal year 2025. That figure is pre-filled in the calculator above and refreshed daily.
How do I calculate BCRX's fair value with a DCF?
Project BioCryst Pharmaceuticals, Inc.'s free cash flow forward at your assumed growth rate, discount each year back at your required return (WACC), add a terminal value, and divide by shares outstanding. The calculator above does all of this instantly as you adjust the assumptions.
What growth rate should I use for BCRX?
Anchor on history and sector reality: look at BioCryst Pharmaceuticals, Inc.'s revenue and cash flow growth over the past five to ten years, then ask what is sustainable going forward. Testing a conservative and an optimistic scenario matters more than any single number.
Is BCRX undervalued right now?
That depends on the assumptions you feed the model — that is the point of running your own DCF. For an independent reference, Fair Price Index publishes a daily fair value for BioCryst Pharmaceuticals, Inc. blending DCF, relative valuation, and analyst consensus.
GET ALERTS
Track BCRX's fair value daily
Download Fair Price Index and get notified when BioCryst Pharmaceuticals, Inc.'s valuation shifts.
Free tier available · PRO $2.99/month
RELATED
STOCK
BCRX Stock Analysis
Full fair value breakdown, FPI Rating, and fundamentals for BioCryst Pharmaceuticals, Inc..
Open →TOOL
DCF Calculator
The general-purpose version — search any of 37,000+ stocks.
Open →ARTICLE
DCF Model Explained
How discounted cash flow works, step by step, with worked examples.
Read →This calculator is for educational purposes only and does not constitute investment advice. Pre-filled figures come from the latest reported financials and may differ from other sources. Always verify against the company's filings.